In determining zone diameter breakpoints, the error-rate bounded method focuses directly on the observed discrepancy percentages very major, major, and minor. These percentages, however, are quite variable due to the number of isolates investigated, the drug-speci c relationship between MIC and zone diameter, the location of the isolates relative to the MIC intermediate zone, and the inherent variability of each test. To overcome potential sampling problems, a hierarchical model is proposed which explicitly accounts for each of these factors and probabilities from this model are used to determine diameter breakpoints. A simulation study is performed to demonstrate the improved consistency of this model-based procedure. Application to three published scatterplots demonstrate its interpretability advantages.
INTRODUCTION
In recent y ears, due to the increasing number of isolates that are marginally susceptible or resistant, the need for a statistically sound zone diameter DIA breakpoint procedure has intensi ed. This has resulted in an empirical reevaluation of the commonly used error-rate bounded method Metzler and DeHaan, 1974; Brunden et al., 1992 . While published scatterplots provide insight i n to tolerable percentage limits as well as factors a ecting the observed percentages, unfortunately because of cost, repeat experiments same drug and isolates have rarely been performed or published. This makes it very di cult to assess the procedure's consistency. Do repeat experiments using the error-rate bounded method result in a consistent set of DIA breakpoints or does the variation in the observed test results a ect breakpoint selection?
When repeat experiments cannot be obtained in practice, it is often helpful to develop a model to simulate them. In this paper, a hierarchical model is described which can be used not only for simulation purposes but also as part of an alternative approach to breakpoint determination. The key to the model is that it distinguishes between an underlying truth and what is observed in practice. This simpli es the process of incorporating experimental variability, the relationship between DIA and MIC, and the distribution of isolates as well as make it possible to describe the performance of each test in terms of its ability probability curve to correctly classify an isolate.
Because this performance depends on the choice of breakpoints, an alternative approach to breakpoint determination based on this model is to make the two tests as similar as possible in terms of performance. The MIC performance curve is xed due to xed breakpoints so DIA breakpoints are found which best equate" the two curves. Not only is this approach more intuitive since it allows a performance-oriented comparison of di erent breakpoint sets, but it also removes the need to have tolerable discrepancy percentages and interval width restrictions. The observed test results are used to estimate the model parameters and not directly in the breakpoint procedure. In practice, because one needs to estimate the model parameters, this approach is more time consuming to implement but it is felt that the consistency and interpretability bene ts far outweigh this limitation.
MATERIALS AND METHODS
In the MIC test, two-fold dilutions are performed with the MIC being the lowest two-fold dilution without visible growth. For the remainder of this paper, consider the MIC in terms of log base 2 units so that the test results are integer values e.g., 0.25 g ml = -2, 1.0 g ml = 0, and 2 g ml = 1. This is done simply to have the di erent dilutions equally-spaced on the number line, similar to the zone diameter DIA results.
The Model
The model is constructed to describe a scatterplot of MIC DIA pairs in terms of Normal distributions thereby allowing simple computation of discrepancy percentages and other probabilities of interest. The model separates the scatterplot into three components: 
Experimental Variation
Quality control experiments have shown a common three-fold range in the observed MIC. This range is attributed to inherent experimental variability. To describe the distribution of the observed MIC, a Normal distribution is used where all values are rounded up to the next highest integer. Thus, any value between 0 and 1 will be rounded to 1 and any value between -2 and -1 will be rounded to -1. The rounding up is due to the fact that lack of growth is only detected in dilutions above the MIC. For example, if the observed MIC were truly 1.43, the lowest test dilution level with no growth would be 2. In terms of an equation, for isolate i, the observed MIC
where d e is the ceiling function rounds up to next largest integer, m i is the true MIC and i is distributed N0; x . The probability that the observed MIC x i for isolate i will be integer z is simply the area under the Normal distribution between z , 1 and z. Thus,
where is the standard Normal cumulative distribution function CDF.
In a similar fashion, the observed DIA
where rounds to the nearest integer, d i is the true DIA and i is N0; y . Instead of rounding up, the disk di usion test rounds the diameter to the nearest millimeter. The probability the observed DIA, y i , equals z is the area under the Normal distribution except between z , 0:5 and z + 0 :5 because of the di erent rounding.
Because these tests are done separately, it is assumed that testing errors i and i are independent. In addition, the model currently assumes the experimental standard deviations, x and y , remain constant over the range of possible MIC or diameter values. This can bealtered if one is concerned that the diameter variability increases with size.
True MIC DIA Relationship
In order to form a scatterplot of observed MIC DIA pairs, the relationship between MICs and zone diameters must be described. Since the model distinguishes between the observed and true results, this relationship is described in terms of the true values. Speci cally, 
Underlying Distribution of MICs
It has been empirically demonstrated that discrepancies most often occur near the intermediate region. This means that the discrepancy percentages depend heavily on the location or distribution of the isolates. To allow for multi-modality and skewness in this distribution, the model uses a mixture of Normal distributions. Speci cally, m = k X j=1 w j Nm; j ; j where j , j , and w j are the mean, standard deviation, and weight o f t h e jth Normal P w = 1.
A mixture of Normals has been shown to be a simple yet exible approach to describe non-Normal distributions Roeder and Wasserman, 1997; Richardson and Green, 1997 
where is the standard Normal CDF. By looking at a range of m's, one forms a curve which describes the performance of the MIC test.
The same curve can beconstructed for the DIA test given breakpoints D L and D U and the function which equates each true MIC with a true DIA. The probability
Notice that since the diameter test is rounded to the nearest millimeter and inversely related to MIC, the probability formula is slightly di erent. If the two tests performed similarly, these two curves would look alike. Since the DIA curve depends on the choice of DIA breakpoints, a search is performed to nd DIA breakpoints which best equate" the two performance curves. Equate is put in quotes because the experimenter may want to nd as similar a curve under additional restrictions, such as limiting the intermediate zone size to no more than 4 mms. Regardless of the choice of restrictions, similar to Brunden et al.'s 1992 use of an index, a loss for a set of breakpoints can bede ned. For this paper, the loss is de ned to be
where f is a distribution which w eights or gives more importance to certain regions of the curve. For example, one choice of weights would be the underlying distribution of isolates fu = u.
Others would be to more heavily weight those values near the MIC breakpoints or give equal weight to all values fu = 1. The min function is used because the goal is to nd DIA breakpoints which are at least as goodas the MIC test. Therefore, there is no loss at a speci c MIC if the probability of the DIA test is higher.
While this integral may appear di cult to compute, one can approximate it quite easily using area under the curve approximations. For example, for a set of n equally spaced m's which span the likely range for MICs, one can compute weights w i = fm i = P fm and estimate L using
Bayesian Inference
In order to use this procedure in practice, one needs to estimate the model parameters i.e., x ; y , and the 's from a scatterplot. Because of the complexity of the model, a simple estimation procedure like linear regression cannot be used. While this is a limitation of this approach, estimation can beperformed using simulation-based inference methods. For this paper, Bayesian inference, enabled by Markov chain Monte Carlo MCMC Smith and Roberts, 1993; Green, 1995 is utilized. One of the powerful features of a Bayesian analysis is that instead of a single set of estimated parameters, one obtains a distribution of likely sets of parameters posterior distribution. Thus, instead of a single breakpoint estimate, one can compute breakpoints for each set of parameters thereby creating a posterior distribution of breakpoint pairs. Since this distribution factors in the uncertainty in the parameters, the results are no longer dependent on one set of estimates and one can assess how likely each pair is the correct choice. Eventually this MCMC algorithm will be available as software. For further details on this approach see Craig 1999.
RESULTS
To better understand the model, a set of model parameters to be used in the simulation study are presented in several gures which summarize how the three components of the model t together and how the probability curve is used to determine breakpoints. The simulation study is then presented to assess consistency followed by applications to three scatterplots of the drug Lome oxacin.
The Model Experimental Variability
The rounding of a Normal distribution is used to describe the inherent variability because 1 it allows the true MIC or DIA to be measured on a continuous scale while the observed MIC or DIA is considered an integer, 2 it uses the common Normal distribution description of experimental variability and 3 it allows great exibility in the shape of the observed MIC distribution. While the Normal distribution is symmetric, one can see from Figure 1 that the shape of the observed MIC distribution depends on the mean and that with x = 0:5 the results are consistent with the common three-four dilution range observed in quality control studies. One can also see the implications of the variation and rounding in terms of the probability o f correct identi cation. If the MIC breakpoints were -1 and 1, all three of these true MICs means are in the intermediate range. However, in terms of the observed results, the second and third isolates are most likely going to be classi ed as resistant x 1. While a discrepancy depends on both test results, this rounding up suggests that very major discrepancies MIC = R would be more likely than major MIC = S. A result that does not agree with the current tolerable percentage restrictions.
Underlying Relationship of MIC and DIA
The distribution of isolates in terms of MICs is described using a mixture of Normal distributions. These MICs are then linked to the true diameter zones using the drug-speci c formula. 
Diameter Breakpoint Determination
To assess the performance of the MIC test at any true MIC level, one only needs to know the MIC breakpoints and the testing variance x . Figure 3 plots the probability of correct identi cation over a range of MIC values using x = :5 and common one dilution intermediate region. Due to the testing variability and rounding, this probability decreases as the true MIC approaches a breakpoint from below see also the last two isolates in Figure 1 . This suggests that if the observed result is susceptible, there is a very good chance that it truly is susceptible. On the other hand, if the observed result is resistant, there is a good chance it is truly intermediate. Using y and the parameters from Figure 2 , DIA curves for four sets of DIA breakpoints are shown in Figure 4 . Also included is ,2 logL when f gives equal weight to all possible MIC values i.e., w i = 1. The set of breakpoints which maximizes ,2 logL also minimizes L. 
Simulation Study
To assess the consistency of this procedure and the error-rate bounded method, two versions of repeated tests were simulated. For the rst situation, a set of 300 isolates representative of all species likely to be tested" NCCLS, 1995 were chosen randomly and 100 scatterplots were generated from this set. For the second situation, a new representative" set of 300 isolates was randomly chosen for each experiment. This introduces another source of variability i n to the scatterplot, location of the isolates. The scatterplots were created using the model parameters from Figure 2 . Recall this is a situation where there were a few isolates near the MIC breakpoints which is favorable to the error-rate bounded method low observed discrepancy percentages. For each of the 200 scatterplots, breakpoints were determined using both the error-rate bounded method and the new methodology. For the error-rate bounded method, the best set of breakpoints was the set which maximized 1=E where E = .6VMaj + .3Maj + .1Min
This index gives more weight to a more severe" discrepancy and roughly follows the the discrepancy limits 1.5, 3.0, and 10.0. Other indices see Brunden et al., 1992 were investigated and the results comparable. For the new methodology, from each scatterplot, 50 sets of likely parameters were generated using MCMC. For each set of parameters, the breakpoints were determined using the loss function of this paper and the most frequent set of breakpoints never had ties was selected. Table 1 summarizes the results where the same set of isolates are used throughout. Table 2 summarizes the situation when a new set of isolates was chosen for each experiment. Since the parameters that generated the scatterplots were used in Figure 4 , the appropriate breakpoints in terms of performance should be around 26,32 and in terms of the index E around 25,32. This latter set is based on using the model parameters to compute the exact probability o f a v ery major, major, and minor discrepancy for di erent DIA breakpoints.
In both cases, the consistency less variability of the new methodology is very apparent. The model approach selected a breakpoint set in the rectangular region 252; 321 100 and 99 of the time while the error-rate bounded selected a set in this region 61 and 42 of the time. Since the model explicitly describes sources of variability in the scatterplot, there is less variability i n t h e results. Also, one of the major limitations of the error-rate bounded procedure is its dependence on the isolates selected and this is demonstrated by the increased variability in situation 2. For the new procedure, however, only the experimental variabilities and the true DIA MIC relationship are used to determine breakpoints so as long as the new set of observed results provide similar estimates of these parameters, the breakpoint set will be similar. Thus, for the model-approach, there is only a slight di erence in the two situations and this is re ected in the results.
Application to Published Scatterplots
This new methodology was applied to three scatterplots for the evaluation of Lome oxacin Jones et al., 1988; Cormican and Jones, 1995; Cormican et al., 1996 . The 1988 scatterplot gave preliminary recommendations for zone diameter breakpoints which w ere later accepted by NCCLS. The latter two scatterplots were the result of a reevaluation of Lome oxacin and both articles suggest a 2 m m decrease in the accepted breakpoints. The results of the rst scatterplot, for several choices of DIA breakpoints, are summarized in Table 3 and the latter two scatterplots are summarized in Table 4 .
In Table 3 , each set of breakpoint satis es the 1.5 and 3.0 restrictions but all have a minor percentage slightly greater than 10. While the set 18,22 was chosen, any of these other sets would have su ced under the discrepancy restrictions. Was the set 18,22 chosen because it had the fewest minor errors and smallest intermediate range? Why is it better than the set 19,23 which has over half as many very major discrepancies? While an index can beformulated to include each of the experimenter's goals, the simulation study has shown that any decision based on discrepancy percentages is highly variable and can likely change with a new study. On the other hand, the model approach w as shown to be very consistent and allows comparisons of breakpoints sets using performance curves. The model approach results, based on 500 likely sets of parameters, are summarized in Table 5 . Over 70 of the time, the set 18,23 resulted in the most favorable performance curve. In reference to the choice 18,22, this suggests that a reduction in the performance in the susceptibility region 22 ! 23 is outweighed by the increase in performance in the intermediate region. Without plotting the curves, however, it is di cult to know exactly what this trade-o entails.
The main reason for choosing these three scatterplots was to see whether the new methodology when applied to the latter two scatterplots would agree with a reduction in the breakpoints. The model approach summaries are in Table 5 . While the results agree with a decrease in breakpoints, the two scatterplots do not suggest the same choice of breakpoints. Since the simulation study showed that this procedure is quite consistent e v en when di erent isolates are chosen, this suggests that there is either a di erence in experimental variances or underlying relationship between DIA and MIC. In looking at the sets of likely parameters for each scatterplot, there are two major di erences. First, the DIA testing error is estimated to be much larger in the 1996 scatterplot 1995 mean 2.1 vs 1996 mean 3.5. Since the 1996 scatterplot is a collection of results performed at numerous labs and the model does not factor in lab to lab variability, it is not surprising that the variability is larger. Second, the 1996 scatterplot has a much larger percentage of susceptible isolates which suggest an even greater curvilinear relationship between DIA and MIC. Both of these di erences explain the wider zone range estimates with the 1996 data set. In reference to the proposed set 16,20, it appears a decrease in the lower breakpoint w ould increase the performance in the resistant region. The upper breakpoint appears to be satisfactory although further analysis into the 1996 scatterplot would be warranted before any formal recommendations should be made.
DISCUSSION
Because of the increasing number of moderately susceptible and resistant isolates, choosing appropriate breakpoints has become more of a statistical problem. The error-rate bounded method, while simple to implement, is too sensitive to the variability in the observed frequencies caused both by the inherent experimental error in each test and the choice location of the isolates relative to the intermediate zone. A model approach has been presented which, by explicitly describing these factors, has much better statistical properties and provides a more intuitive performance oriented approach o f determining breakpoints. Instead of using the observed results directly in breakpoint determination, the model approach uses the observed results to estimate the model parameters which in turn determine the breakpoints. In a sense, the model lters out a goodportion of the noise observed in a scatterplot leaving just the true relationship between DIA and MIC and the testing variances. Also unlike the error-rate bounded method, the number and location of the isolates does not a ect the choice of breakpoints except through the estimation of the model parameters. This is why the model approach i s s o m uch more consistent than the error-rate bounded approach and also why this approach can handle more isolates near the intermediate region without having to make adjustments e.g., altering the tolerable percentages. While eliminating disagreements between two tests error-rate bounded method is often an appropriate method of calibration, it does not necessarily work when the two tests behave di erently. Since the MIC test rounds up, it is more conservative less likely to say an isolate is susceptible than the disk test. Simply bounding the discrepancy percentages does not take this behavior into account. It is more natural to observe a v ery major discrepancy compared to a major discrepancy but this has the lowest percentage restriction. The performance curves, on the other hand, are based on each test's ability in terms of probability to classify an isolate and therefore uses these rounding procedures in the calculations.
It should be noted, that since the data in the simulation study were generated from the model, one would expect the model approach to do well. Also, the error-rate bounded method is not usually based on an index but rather the nal decision is based on secondary factors such as past studies, zone diameters restrictions and breakpoints of similar drugs. It is very likely that for most experiments the set 25,32 satis ed the discrepancy limits and could have been selected. The problem is explaining why this set should be selected over others. An index provides an explanation but since it depends on the observed percentages is highly variable. One could use the model parameters to compute the index, thereby removing some of the variability in the percentages but this does not remove the dependence on the distribution of the isolates which m a y c hange over time. The performance approach, on the other hand, does not change with the distribution thereby providing a more stable and understandable result.
This model approach to determination is considered more intuitive because the performance curves do not directly depend on the observed results and the MICs location relative to the MIC intermediate zone. It also provides a visual description of each test rather than a joint n umerical summary. However, similar to error-rate bounded procedure, how to utilize these curves to determine breakpoints in terms of a loss function is left to the experimenter. This paper focused on a loss function that simply tried to make the DIA test as least as powerful as the MIC test and depend solely on the experimental errors and relationship between MIC and DIA. Other loss functions, for example one that limits the intermediate zone size, are perfectly acceptable and should be used if there are other goals.
The performance curve depends not only on the choice of breakpoints but also the model selected. While it is felt this model adequately describes scatterplots, variations such as allowing for increasing variance in the DIA test or a di erent relationship between DIA and MIC can be included and are currently under review. This same methodology can also be applied in device testing where NCCLS approved procedures usually MIC lab tests are compared with device results. At the present time, a variation of error-rate bounded procedure is performed where device and lab results must be more than one dilution apart in order to be considered a discrepancy. With this methodology, one would assume that the MIC and device d results are linearly related d i = 0 + 1 m i and could use this same procedure to see if 1 0 = 0 and 1 = 1, the device is unbiased. It would also take into account the location of the isolates investigated and eliminate the need for similar tolerable percentages. ACKNOWLEDGMENTS I would like to thank William A. Craig and the other members of the NCCLS Subcommittee on Antimicrobial Susceptibility T esting for explaining the problem and procedures as well as giving me numerous inciteful comments about the the model as it was being developed. I w ould also like to thank George McCabe, George Casella, Raymond Carroll, Michael Newton and Michael Black for their helpful comments and suggestions. a The left numb e r i n e a c h cell is for the error-rate bounded procedure and the right for the new methodology. 
